345508 <common-name>(2s,4s,5s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-6-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]-4-hydroxy-2-propan-2-ylhexanamide</common-name> <description>(2s,4s,5s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-6-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]-4-hydroxy-2-propan-2-ylhexanamide is a chemical compound with the formula C26H42ClN5O4. With an average molecular weight of 524.10 g/mol, (2s,4s,5s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-6-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]-4-hydroxy-2-propan-2-ylhexanamide is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>57519702</pubchem-id> <chemical-formula>C26H42ClN5O4</chemical-formula> <weight>524.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:18:39Z</created-at> <updated-at type="dateTime">2026-08-31T08:18:39Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)C(CC(C(CN1CC(=O)N(CC1(C)C)C2=CC=CC=C2Cl)N)O)C(=O)NCC(C)(C)C(=O)N</moldb-smiles> <moldb-formula>C26H42ClN5O4</moldb-formula> <moldb-inchi>InChI=1S/C26H42ClN5O4/c1-16(2)17(23(35)30-14-25(3,4)24(29)36)11-21(33)19(28)12-31-13-22(34)32(15-26(31,5)6)20-10-8-7-9-18(20)27/h7-10,16-17,19,21,33H,11-15,28H2,1-6H3,(H2,29,36)(H,30,35)/t17-,19-,21-/m0/s1</moldb-inchi> <moldb-inchikey>RBIIKVXVYVANCQ-CUWPLCDZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">523.2925325</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341401</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2s,4s,5s)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-6-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]-4-hydroxy-2-propan-2-ylhexanamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0295865</sync-id> <structure-inchikey>RBIIKVXVYVANCQ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000000000000000008100000020000008000000000000041000001000000000000010400000200000000000020000008000400000000000000000010000020000000000004004000000200000000000200000008000000c0000000000080800002003010000000000000000000080001000020100002000020000000040000000000048000010800000000000020080001000000100000000000000000020000100000000000000000080080000000000000000004000000400000000001040000100000000000000000000010000000010000000800000000200000400000008008000008000000040000000000420000020000000000000000010000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJQAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDBgBgAAAAAwEGAGAAAAACAgYAYAAAAAMBBgBgAAAAAwEGAGAA AAACAgcAIAAAAAMGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYA YAAAAAICBgAgAAAABAYAYAAAAAEDBgBgAAAAAQMGQCgAAAADBAZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEEQAgAAAAAQcA YAAAAAECCABgAAAAAQEGACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBgBgAAAA AgIGACAAAAAEBgBgAAAAAQMGAGAAAAABAwYAKAAAAAMECAAoAAAAAwIHAGgA AAADAQILAAEAAQIAAQMAAwQABAUABQYABgcABwgACAkACQoACgsoAgoMIAwN AA0OAA4PAA4QAAwRIBESaAwSE2gMExRoDBQVaAwVFmgMFhcABhgABRkAAxoA GhsoAhocIBwdAB0eAB4fAB4gAB4hACEiKAIhIyAOCAAWEWgMQgIAAAAGCA4N DAoJBhITFBUWERcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:32Z</structure-indexed-at> </compound>